lohud.com

Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Acorda reports $18.8 million loss

August
5

Acorda Therapeutics Inc., the pharmaceutical company based in Hawthorne, said this morning it lost $18.8 million, or 58 cents a share, during the quarter that ended in June.

During the corresponding quarter in 2007, the company, which markets Zanaflex, a treatment for involuntary muscle movements caused by multiple sclerosis and spinal injuries, lost $8.2 million, or 33 cents a share.

Net sales rose to $11.36 million from $9.48 million.

The company is also seeking to develop Fampridine-SR, a drug to help people with multiple sclerosis walk.

Dr. Ron Cohen, the president and chief executive of the company, said in a statement released by the company. “Acorda continued to achieve important milestones in this quarter.”

This entry was posted on Tuesday, August 5th, 2008 at 8:46 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: del.icio.us Digg | Print Print | Email Email

Advertisement

Leave a Reply

About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.

Enter your email address to get daily updates from Business in the Burbs sent to your inbox:

About the Authors

Categories

Other recent entries


Latest LoHud Business news


Links

Monthly Archives

Bad Behavior has blocked 3604 access attempts in the last 7 days.